Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy
PA Prieto, KH Durflinger, JR Wunderlich… - Journal of …, 2010 - journals.lww.com
Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic
melanoma has shown objective response rates as high as 72%. The successful application …
melanoma has shown objective response rates as high as 72%. The successful application …
Enrichment of CD8+ Cells from Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy
PA Prieto, KH Durflinger… - Journal of …, 2010 - pure.johnshopkins.edu
Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic
melanoma has shown objective response rates as high as 72%. The successful application …
melanoma has shown objective response rates as high as 72%. The successful application …
[HTML][HTML] Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy
PA Prieto, KH Durflinger, JR Wunderlich… - Journal of …, 2010 - ncbi.nlm.nih.gov
Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic
melanoma has shown objective response rates as high as 72%. The successful application …
melanoma has shown objective response rates as high as 72%. The successful application …
Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy
PA Prieto, KH Durflinger, JR Wunderlich… - Journal of …, 2010 - journals.lww.com
Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic
melanoma has shown objective response rates as high as 72%. The successful application …
melanoma has shown objective response rates as high as 72%. The successful application …
Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy.
PA Prieto, KH Durflinger, JR Wunderlich… - Journal of …, 2010 - europepmc.org
Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic
melanoma has shown objective response rates as high as 72%. The successful application …
melanoma has shown objective response rates as high as 72%. The successful application …
Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy
PA Prieto, KH Durflinger… - Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for metastatic
melanoma has shown objective response rates as high as 72%. The successful application …
melanoma has shown objective response rates as high as 72%. The successful application …
[引用][C] Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy
PA PRIETO, KH DURFLINGER… - Journal of …, 2010 - pascal-francis.inist.fr
Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals
Tumor Reactivity for Use in Adoptive Cell Therapy CNRS Inist Pascal-Francis CNRS Pascal …
Tumor Reactivity for Use in Adoptive Cell Therapy CNRS Inist Pascal-Francis CNRS Pascal …